IP Portfolio Growth The firm specializes in writing and reviewing infringement and validity opinions on patents in molecular genetics and advises on IP portfolio development, suggesting opportunities to cross-sell advanced patent strategy, freedom-to-operate analyses, and international patent prosecution services to expand clients’ portfolios.

Life Sciences Focus With experience spanning biological, chemical, and medical device technologies and a track record with pharmaceutical companies, biotechs, universities, and research institutions, there is a clear opportunity to target segmented life sciences companies needing patent strategy and clearance work.

Strategic Alliances Leverage relationships as outside and in-house counsel to offer ongoing regulatory compliance, licensing negotiations, secrecy agreements, and collaborative research arrangements to deepen client engagement and create recurring legal services revenue.

Regional Growth Potential Despite a modest headcount, the firm cites substantial revenue, indicating efficiency in delivering high-value IP services. Cross-sell to larger firms’ clients seeking specialized genetics patent expertise or expand to international patent prosecution for clients pursuing global markets.

Competitive Distinction Position the firm as a niche genetics patent specialist within a competitive landscape of large IP firms, emphasizing specialized expertise, tight client focus, and flexible engagement models to win bids from midsize and boutique firms handling biotech IP matters.